logo
Plus   Neg
Share
Email

Hikma Pharma Launches New Prefilled Syringes In US

Hikma Pharmaceuticals PLC (HIK.L, HKMPY) announced Tuesday that the company, through its affiliate, Hikma Pharmaceuticals USA Inc., has launched a new prefilled syringe capability in the U.S.

Heparin Sodium Injection in a ready-to-use syringe is the first product using Hikma's new injectable manufacturing capability

The Heparin Sodium Injection, USP, 5000 Units/mL is indicated for prophylaxis and treatment of venous thrombosis and pulmonary embolism, among others.

Dan Motto, Hikma's EVP of Commercial & Business Development, US Injectables, said, "Our Heparin Sodium Injection prefilled syringes are ready-to-administer and will help hospitals, pharmacists, doctors and nurses treat patients faster, more easily and with reduced risk."

Hikma said it is the third largest US supplier of generic injectable medicines by volume, with a growing portfolio of over 100 products. According to the company, one in every six injectable generic medicines used in US hospitals is a Hikma product.

In London, Hikma shares are currently trading at 1,973 pence, up 1.86 percent.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Polaris Industries Inc. is recalling certain Ranger and General Utility, as well as All-Terrain vehicles citing risks of crash, the U.S. Consumer Product Safety Commission said in a statement. The Medina, Minnesota-based company has called back about 26,730 units of Model Year 2019 - 2020 Ranger XP 1000 & Model Year 2020 General XP 1000 Utility vehicles. Gilead Sciences Inc. (GILD) said Friday that the European Commission has granted conditional marketing authorization for Veklury or remdesivir as a treatment for SARS-CoV-2 infection, the virus that causes COVID-19. FedEx is asking NFL team Washington Redskins to change its name for its racist connotations. The delivery services company, which is a major sponsor for the team, made the suggestion following increasing pressure from its investors amid the ongoing protests against racial injustice and inequality that arose from the killing of African-American George Floyd.
Follow RTT